Drugmaker AstraZeneca announced on Monday that its experimental 코로나 바이러스 vaccine has shown an average efficacy of 70% in its large scale trials — the latest of several vaccine trials worldwide to post their results this month.
The vaccine, developed with the University of Oxford, showed 90% efficacy in one dosing regimen — when the vaccine was given as a half dose, followed by a full dose at least a month later — 과 62% efficacy in a second regimen — when two full doses were given at least a month apart.
That averages to a 70% efficacy, AstraZeneca said.
The company said in a news release that its vaccine was “highly effective in preventing COVID-19, the primary endpoint, and no hospitalisations or severe cases of the disease were reported in participants receiving the vaccine.”
The interim analysis included a total of 131 코로나 19 사례, 릴리스에 따라.
Monday’s news comes after Moderna announced earlier this month that its vaccine was 94.5% effective against coronavirus, 과 화이자 announced its vaccine was 95% 유효한.
이것은 발전하는 이야기입니다 … more to follow
